Reid M M - OmicsDI

Show results for

Unknown (2385)
Transcriptomics (95)
Proteomics (66)
Genomics (22)
Metabolomics (4)
Genomic (1)

Organisms

Homo sapiens (53)
Vitis vinifera (13)
Mus musculus (11)
Rattus norvegicus (5)
Arabidopsis thaliana (5)
Zea mays (4)
Helicoverpa zea (2)
Drosophila melanogaster (2)
Medicago truncatula (2)
Botrytis cinerea (1)
Botrytis cinerea B05.10 (1)
Vitis riparia (1)
Lucania goodei (1)
Euglena gracilis (1)
Quercus suber (1)
Musca domestica (1)
Anopheles stephensi (1)
Dictyostelium discoideum (1)
Eimeria tenella (1)
Neospora caninum (1)
Plasmodium chabaudi chabaudi (1)
Macaca mulatta (1)
Toxoplasma gondii (1)
Listeria monocytogenes (1)
Plasmodium falciparum 3D7 (1)
mixed sample (1)
Hordeum vulgare (1)
Bos taurus (1)
Saccharomyces cerevisiae (1)
Sinorhizobium meliloti (1)

Organisms

Medicago truncatula (1)

Repository

biostudies-arrayexpress (99)
pride (47)
EGA (16)
MassIVE (14)
MetaboLights (4)
iProX (3)
PeptideAtlas (2)
dbGaP (1)
geo (1)
ENA (1)

Tissue

Cell culture (12)
Permanent cell line cell (5)
Kidney (5)
Embryonic stem cell (4)
Heart (4)
Myeloid cell (3)
Myeloid cell line (2)
Whole body (2)
Fibroblast (2)
Female Reproductive System (1)
Ovary (1)
Somatic cell (1)
Cranium (1)
Blood vessel endothelial cell (1)
Cardiomyocyte cell line (1)
Podocyte (sensu Diptera) (1)
Anther (1)
Osteoblast (1)
Tooth enamel (1)
Osteocyte (1)
Breast (1)
Lymph node (1)
Early embryonic cell (1)
Stem cell (1)
Endothelial cell of umbilical vein (1)
Photosynthetic cell (1)
Spleen (1)
Epithelial cell (1)
Saliva (1)
Liver (1)

Disease

Cardiovascular system disease (4)
Amyotrophic lateral sclerosis (4)
Breast cancer (3)
Parasitic helminthiasis infectious disease (3)
Acute myeloid leukemia (3)
Huntington Disease (2)
Disease free (2)
CAMN (1)
E. lata infected plant without symptoms (1)
Infected by E. lata strain NE85-1 (1)
High Grade Ovarian Serous Adenocarcinoma (1)
Bone disease (1)
Mitochondrial metabolism disease (1)
Hepatocellular carcinoma (1)
COVID-19 (1)

Technology Type

Mass Spectrometry (47)
Shotgun proteomics (28)
Data-independent acquisition (5)
Mass spectrometry (4)
Data-dependent acquisition (4)
Bottom-up proteomics (4)
SWATH MS (3)
Chemical cross-linking coupled with mass spectrometry proteomics (3)
Gel-based experiment (2)
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0 (1)
Top-down proteomics (1)
Affinity purification coupled with mass spectrometry proteomics (1)

Instrument Platform

Illumina HiSeq 2500 (5)
Q Exactive (5)
Illumina NovaSeq 6000 (3)
Illumina HiSeq 2000 (3)
NextSeq 500 (3)
LTQ Orbitrap Elite (3)
Q Exactive Plus (3)
LTQ Orbitrap Velos (3)
LTQ Orbitrap XL (2)
TimsTOF Pro (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Illumina Genome Analyzer (1)
GenePix Professional 4200A [Axon Instruments] (1)
GenePix 4000B [Axon Instruments] (1)
DNBSEQ-G400 (1)
HiSeq X Ten (1)
Illumina HiSeq 4000 (1)
Synapt XS (1)
LTQ Velos (1)
TripleTOF 5600 (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2022 (17)
2014 (16)
2012 (15)
2019 (13)
2011 (13)
2013 (10)
2023 (9)
2010 (9)
2024 (8)
2021 (8)
2020 (8)
2015 (8)
2025 (7)
2008 (7)
2017 (5)
2016 (5)
2009 (3)
2018 (3)
2026 (3)
2007 (1)
2006 (1)

UNIPROT ID/AC

Q13465 (2)
Q04743 (2)
Q9P2J2 (2)
Q96DX8 (2)
Q96RV3 (2)
P25105 (2)
Q9NV29 (2)
A8K0R7 (2)
Q969W3 (2)
Q86YS3 (2)
Q6GPH4 (2)
B7ZBB8 (2)
Q99983 (2)
Q9GZY0 (2)
Q969W3-2 (2)
Q6ZUK4 (2)
A8MYZ6 (2)
Q9Y4X4 (2)
Q9UIL8 (2)
Q8IZL2 (2)
P09017 (2)
Q8N6G6 (2)
P01769 (2)
Q6ZUS6 (2)
Q8IVB4 (2)
Q8N2G6 (2)
Q9ULL0 (2)
Q9UIG8 (2)
Q9NYQ8 (2)
Q9H246 (2)

ENSEMBL ID

ENSG00000204131 (2)
ENSG00000147251 (2)
ENSG00000229353 (2)
ENSG00000247315 (2)
ENSG00000170477 (1)

CHEBI ID

CHEBI:16870 (4)
CHEBI:15891 (3)
CHEBI:42111 (2)
CHEBI:18344 (2)
CHEBI:36274 (2)
CHEBI:16946 (2)
CHEBI:15699 (2)
CHEBI:16857 (2)
CHEBI:16828 (2)
CHEBI:16010 (2)
CHEBI:37550 (2)
CHEBI:30797 (2)
CHEBI:15354 (2)
CHEBI:73024 (2)
CHEBI:16704 (2)
CHEBI:16335 (2)
CHEBI:16919 (2)
CHEBI:18237 (2)
CHEBI:140755 (1)
CHEBI:84399 (1)
CHEBI:166733 (1)
CHEBI:167290 (1)
CHEBI:186106 (1)
CHEBI:187845 (1)
CHEBI:229496 (1)
CHEBI:60125 (1)
CHEBI:88475 (1)
CHEBI:28115 (1)
CHEBI:145324 (1)
CHEBI:166709 (1)

Metabolite Name

Sn-glycero-3-phosphocholine (2)
Choline (2)
L-cysteinylglycine disulfide (1)
4-hydroxy-2-oxoglutarate (1)
O-acetylcarnitine (1)
Cervonyl carnitine (1)
Timnodonyl carnitine (1)
Sphingosine-1-phosphate (1)
L-citrulline (1)
O-acetyl-l-serine (1)
FA(8:0) (1)
Glycochenodeoxycholic acid (GCDCA) (1)
Glycocholic acid (GCA) (1)
Glycodeoxycholic acid (GDCA) (1)
Glycolithocholic Acid sulfate (1)
P-Hydroxybenzoic acid (1)
FA(6:0) (1)
Taurochenodeoxycholic Acid (TCDCA) (1)
Taurohyocholic acid (THCA) (1)
Taurolithocholic acid -3-O-sulfate (1)
3a,6a,7a,12a-Tetrahydroxy-5b-cholanoic acid (2a,3a,7a,12a-THBA) (1)
FA(13:0) (1)
Vanillomandelic acid (VMA) (1)
Dioxolithocholic acid (1)
CL(18:2/18:2/18:2/18:1) (1)
Homovanillic acid (HVA) (1)
N-Carbamoyl-L-aspartic acid (1)
LXA4 (1)
PE(P-18:1/18:2) (1)
PI(18:2/22:6) (1)

First Public Date

2014 (1)

Modification

Not available (1)

Study type

Transcription profiling by array (44)
RNA-seq of coding RNA (23)
Methylation profiling by array (8)
Comparative genomic hybridization by array (4)
Other (4)
ChIP-seq (2)
Methylation profiling by high throughput sequencing (2)
RNA-seq of total RNA (2)
ChIP-chip by tiling array (1)
Plant - High-throughput sequencing (1)
Trajectory (1)
RNAi profiling by array (1)
Genotyping by array (1)
Transcription profiling by RT-PCR (1)
MicroRNA profiling by array (1)
DNA-seq (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of non coding RNA (1)

Release Date

2021 (278)
2023 (262)
2022 (257)
2025 (233)
2024 (200)
2020 (179)
2019 (151)
2018 (149)
2017 (105)
2015 (104)
2014 (97)
2016 (94)
2013 (83)
2012 (64)
2011 (56)
2010 (45)
2009 (33)
2026 (27)
2008 (26)
2007 (14)
2006 (9)
2004 (5)
2003 (4)
2005 (3)
2001 (3)
2002 (1)
2000 (1)
1999 (1)

Lab affiliation

Department of Biochemistry and Molecular Biology; and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, VIC 3010. Australia (3)
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne (2)
Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. (2)
School of Life and Environmental Sciences, University of Sydney, NSW 2006 Australia (2)
Cardiac Bioengineering group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia (2)
Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. (2)
Dept. of Laboratory Medicine University of California, San Francisco, USA (2)
Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia (2)
NHMRC Senior Research Fellow Department of Biochemistry and Molecular Biology | Faculty of Medicine, Dentistry and Health Sciences Level 2 South, Bio21 Molecular Science and Biotechnology Institute, 30 Flemington Road The University of Melbourne, Victoria 3010 Australia (2)
CRUK Beatson Institute (2)
Wellcome Centre for Cell-Matrix Research, Division of Molecular and Cellular Function, University of Manchester, UK (1)
Department of Veterinary Biosciences, Melbourne Veterinary School, The University of Melbourne, Australia (1)
1.Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. (1)
QIMR Berghofer Medical Research Institute (1)
Department of Biology, Dalhousie University, Halifax Nova Scotia Canada B3H-4R2 (1)
The Laboratory of Craniofacial Development and Biology, Section of Plastic and Reconstructive Surgery, University of Chicago Medicine (1)
Multi-Organ Transplant, and Division of Nephrology, Department of Medicine. University Health Network, Toronto, Ontario, Canada. (1)
Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia 6009, Australia (1)
Infection Biology (1)
Toronto General Hospital Research Institute, UniversityHealth Network, Toronto, Canada Department of Medicine, Division of Nephrology, University Health Network, Toronto, Canada (1)
NHMRC Senior Research Fellow Department of Biochemistry and Molecular Biology | Faculty of Medicine, Dentistry and Health Sciences Level 2 South, Bio21 Molecular Science and Biotechnology Institute, 30 Flemington Road The University of Melbourne, Victoria 3010 Australia (1)
Laboratory Medicine and Pathology Mayo Clinic USA (1)
Department of Molecular Biology and Biochemistry,School of Biological Sciences, University of California, Irvine, United States (1)
Center for Advanced Regenerative Engineering, Northwestern University, Evanston, IL 60208, USA (1)
Cardiac Bioengineering Lab, QIMR Berghofer Medical Research Institute, Brisbane, QLD, AUS (1)
Dept. of Laboratory Medicine University of California, San Francisco USA (1)
Professor Anthony W Purcell Deputy Head (Research), Department of Biochemistry and Molecular Biology Head Immunoproteomics Laboratory Monash University, Clayton Campus Clayton 3800 Victoria Australia (1)
Department of Biochemistry and Pharmacology, Bio21 Institute, University of Melbourne (1)
Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia (1)
Cardiac Bioengineering lab, QIMR Berghofer Medical Research Institute, Herston, QLD, AUD (1)

Previous page
1 / 258
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 258
Next page

Sort by:

Relevance

Page size

Targeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.

Not available

S-EPMC3503349 | biostudies-literature

Telehealth interventions to reduce management complications in type 1 diabetes: A review.

Not available

S-EPMC4398894 | biostudies-literature

A Whole Transcriptional Linkage Analysis of Gene Co-Regulation in Insecticide Resistant House Flies, Musca domestica

Illumina HiSeq 2000 RNASeq was conducted on the mRNA fraction of three adult female Musca domestica strains. Two strains were the insecticide susceptible strains CS and aabys, which has five distinct recessive morphological markers, one on each of the five autosomes in M. domestica. The third strain...

ORGANISM(S): Musca domestica

2014-01-02 | E-GEOD-39327 | biostudies-arrayexpress

Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.

Not available

S-EPMC3739862 | biostudies-literature

Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA.

Not available

S-EPMC1634838 | biostudies-literature

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.

Not available

S-EPMC4872349 | biostudies-literature

Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.